Logo image of RCAT

RED CAT HOLDINGS INC (RCAT) Stock Fundamental Analysis

NASDAQ:RCAT - Nasdaq - US75644T1007 - Common Stock - Currency: USD

5.13  -0.05 (-0.97%)

After market: 5.0923 -0.04 (-0.73%)

Fundamental Rating

3

RCAT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 124 industry peers in the Electronic Equipment, Instruments & Components industry. Both the profitability and financial health of RCAT have multiple concerns. RCAT is valued quite expensively, but it does show have an excellent growth rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

RCAT had negative earnings in the past year.
RCAT had a negative operating cash flow in the past year.
In the past 5 years RCAT always reported negative net income.
RCAT had a negative operating cash flow in each of the past 5 years.
RCAT Yearly Net Income VS EBIT VS OCF VS FCFRCAT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

RCAT has a Return On Assets of -74.99%. This is amonst the worse of the industry: RCAT underperforms 89.52% of its industry peers.
RCAT has a worse Return On Equity (-141.75%) than 86.29% of its industry peers.
Industry RankSector Rank
ROA -74.99%
ROE -141.75%
ROIC N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
RCAT Yearly ROA, ROE, ROICRCAT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1K -1K 2K

1.3 Margins

RCAT has a Gross Margin of 10.92%. This is in the lower half of the industry: RCAT underperforms 76.61% of its industry peers.
RCAT's Gross Margin has been stable in the last couple of years.
The Profit Margin and Operating Margin are not available for RCAT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 10.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5YN/A
RCAT Yearly Profit, Operating, Gross MarginsRCAT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -5K -10K -15K

More info and screens

3

2. Health

2.1 Basic Checks

RCAT does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, RCAT has more shares outstanding
Compared to 5 years ago, RCAT has more shares outstanding
Compared to 1 year ago, RCAT has an improved debt to assets ratio.
RCAT Yearly Shares OutstandingRCAT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M
RCAT Yearly Total Debt VS Total AssetsRCAT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

RCAT has an Altman-Z score of 7.53. This indicates that RCAT is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 7.53, RCAT belongs to the top of the industry, outperforming 87.10% of the companies in the same industry.
A Debt/Equity ratio of 0.44 indicates that RCAT is not too dependend on debt financing.
RCAT has a Debt to Equity ratio of 0.44. This is in the lower half of the industry: RCAT underperforms 66.13% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Altman-Z 7.53
ROIC/WACCN/A
WACC8.97%
RCAT Yearly LT Debt VS Equity VS FCFRCAT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M 60M

2.3 Liquidity

RCAT has a Current Ratio of 1.43. This is a normal value and indicates that RCAT is financially healthy and should not expect problems in meeting its short term obligations.
RCAT's Current ratio of 1.43 is on the low side compared to the rest of the industry. RCAT is outperformed by 79.03% of its industry peers.
A Quick Ratio of 0.57 indicates that RCAT may have some problems paying its short term obligations.
RCAT has a worse Quick ratio (0.57) than 91.94% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 0.57
RCAT Yearly Current Assets VS Current LiabilitesRCAT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M 50M

More info and screens

7

3. Growth

3.1 Past

RCAT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 9.62%, which is quite good.
RCAT shows a strong growth in Revenue. In the last year, the Revenue has grown by 49.70%.
The Revenue has been growing by 176.68% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)9.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
Revenue 1Y (TTM)49.7%
Revenue growth 3Y52.8%
Revenue growth 5Y176.68%
Sales Q2Q%-60.96%

3.2 Future

RCAT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 39.49% yearly.
The Revenue is expected to grow by 123.37% on average over the next years. This is a very strong growth
EPS Next Y40.07%
EPS Next 2Y39.61%
EPS Next 3Y39.49%
EPS Next 5YN/A
Revenue Next Year105.93%
Revenue Next 2Y151.19%
Revenue Next 3Y123.37%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RCAT Yearly Revenue VS EstimatesRCAT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2019 2020 2021 2022 2023 2024 2025 2026 2027 50M 100M 150M 200M
RCAT Yearly EPS VS EstimatesRCAT Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0 0.2 -0.2 -0.4

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for RCAT. In the last year negative earnings were reported.
Also next year RCAT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RCAT Price Earnings VS Forward Price EarningsRCAT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -50 -100 -150 -200 -250

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RCAT Per share dataRCAT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4

4.3 Compensation for Growth

A more expensive valuation may be justified as RCAT's earnings are expected to grow with 39.49% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y39.61%
EPS Next 3Y39.49%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for RCAT!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

RED CAT HOLDINGS INC

NASDAQ:RCAT (4/17/2025, 8:00:02 PM)

After market: 5.0923 -0.04 (-0.73%)

5.13

-0.05 (-0.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupTechnology Hardware & Equipment
GICS IndustryElectronic Equipment, Instruments & Components
Earnings (Last)03-31 2025-03-31
Earnings (Next)08-06 2025-08-06/amc
Inst Owners32.55%
Inst Owner Change0.02%
Ins Owners18.14%
Ins Owner Change-7.4%
Market Cap464.32M
Analysts84.44
Price Target14.28 (178.36%)
Short Float %21%
Short Ratio1.85
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-64.08%
Min EPS beat(2)-108.33%
Max EPS beat(2)-19.83%
EPS beat(4)0
Avg EPS beat(4)-87.43%
Min EPS beat(4)-145.1%
Max EPS beat(4)-19.83%
EPS beat(8)1
Avg EPS beat(8)-79.99%
EPS beat(12)2
Avg EPS beat(12)-128.43%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-46.38%
Min Revenue beat(2)-63.55%
Max Revenue beat(2)-29.22%
Revenue beat(4)0
Avg Revenue beat(4)-25.2%
Min Revenue beat(4)-63.55%
Max Revenue beat(4)-1.15%
Revenue beat(8)2
Avg Revenue beat(8)-20.23%
Revenue beat(12)2
Avg Revenue beat(12)-34.16%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.67%
PT rev (3m)40%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-28.57%
EPS NY rev (1m)0%
EPS NY rev (3m)-30.56%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.24%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 28.19
P/FCF N/A
P/OCF N/A
P/B 17.18
P/tB 743.86
EV/EBITDA N/A
EPS(TTM)-0.47
EYN/A
EPS(NY)-0.02
Fwd EYN/A
FCF(TTM)-0.22
FCFYN/A
OCF(TTM)-0.21
OCFYN/A
SpS0.18
BVpS0.3
TBVpS0.01
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -74.99%
ROE -141.75%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 10.92%
FCFM N/A
ROA(3y)-36.1%
ROA(5y)-55.7%
ROE(3y)-39.94%
ROE(5y)-95.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.21%
GM growth 5YN/A
F-Score3
Asset Turnover0.32
Health
Industry RankSector Rank
Debt/Equity 0.44
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 15.07%
Cap/Sales 1.48%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.43
Quick Ratio 0.57
Altman-Z 7.53
F-Score3
WACC8.97%
ROIC/WACCN/A
Cap/Depr(3y)137.29%
Cap/Depr(5y)N/A
Cap/Sales(3y)10.59%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)9.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-10%
EPS Next Y40.07%
EPS Next 2Y39.61%
EPS Next 3Y39.49%
EPS Next 5YN/A
Revenue 1Y (TTM)49.7%
Revenue growth 3Y52.8%
Revenue growth 5Y176.68%
Sales Q2Q%-60.96%
Revenue Next Year105.93%
Revenue Next 2Y151.19%
Revenue Next 3Y123.37%
Revenue Next 5YN/A
EBIT growth 1Y-5.31%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year39.87%
EBIT Next 3Y56.58%
EBIT Next 5YN/A
FCF growth 1Y13.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y8.2%
OCF growth 3YN/A
OCF growth 5YN/A